[go: up one dir, main page]

WO2013039412A1 - The method of filling an intragastric balloon - Google Patents

The method of filling an intragastric balloon Download PDF

Info

Publication number
WO2013039412A1
WO2013039412A1 PCT/PL2012/000091 PL2012000091W WO2013039412A1 WO 2013039412 A1 WO2013039412 A1 WO 2013039412A1 PL 2012000091 W PL2012000091 W PL 2012000091W WO 2013039412 A1 WO2013039412 A1 WO 2013039412A1
Authority
WO
WIPO (PCT)
Prior art keywords
balloon
filling
air
saline
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/PL2012/000091
Other languages
French (fr)
Inventor
Zbigniew Kowalczyk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pulsmed Sp Zoo
Original Assignee
Pulsmed Sp Zoo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pulsmed Sp Zoo filed Critical Pulsmed Sp Zoo
Publication of WO2013039412A1 publication Critical patent/WO2013039412A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0089—Instruments for placement or removal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/003—Implantable devices or invasive measures inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/0036—Intragastrical devices

Definitions

  • the present invention relates to a process of filling an intragastric balloon placed into the stomach of a patient for the treatment of overweight or obesity.
  • a soft balloon For the treatment of obesity or overweight into the stomach of a patient endoscopically is introduced a soft balloon. Introduced into the stomach is a probe with the balloon which when placed in the stomach is filled with saline or seldom with air. The material of which the balloon is made is resistant to gastric juices. The balloon is left in the stomach of the patient for up to 6 or 12 months. After the placement of a balloon the patient receives individual guidance on nutrition and diet. A balloon partially filling the stomach causes a feeling of satiety after eating less food.
  • a balloon placed in the stomach is resistant to gastric contents. However, sometimes there is a risk of a balloon damage and deflation. In this case the patient should immediately contact a doctor to remove the remains of the balloon and to avoid a possible intestinal obstruction.
  • the method consists of filling the intragastric balloon with air or saline combined with a fragrance marker.
  • the balloon inflates with saline and gas, usually air, and afterwards the fragrance marker is given to the balloon. Then at 400-700 ml of saline 50-150 cm 3 of air at atmospheric pressure is introduced into the balloon.
  • Fragrance marker is chosen such that it is soluble in physiological saline.
  • the best markers used are peppermint flavor with density at 20° C of 0,943- 1 ,003 g / cm 3 or eucalyptus-mint flavor with density at 20° C of 0,821 g / cm 3 in the amount of 2-5 cm 3 .
  • the method of filling an intragastric balloon according to the invention does not alter the process of treatment of patients, however it causes the fact that the patient notices the damage of the balloon by feeling the characteristic smell of the fragrance marker used during a surgery, expelled through the mouth with air from the damaged balloon (the patient "burps" with a characteristic smell) or feels a noticeable change in urine smell.
  • the early removal of the damaged balloon and its replacement with the new one will be possible.
  • Another advantage that is achieved by the introduction of a fragrance marker is the increase of the sterility of the physiological saline.
  • the introduction of air into the balloon filled with saline solution is designed to reduce dyspeptic symptoms, occurring immediately after the placement and inflation, by reducing the pressure of the balloon to the gastric pylorus.
  • the method of filling the intragastric balloon according to the invention takes place in the following order: the balloon is inserted through the mouth into the stomach of the patient in the control of the video- endoscope, then by the syringe the balloon is filled with saline solution in the amount of 400 ml, and 50 cm 3 of the air from the operating room is added to the balloon by the same syringe, and then 2 cm 3 of peppermint flavor (or mint-eucalyptus) is injected into it.
  • the flavor is used as a natural flavoring additive to beverages and beverage concentrates.
  • the balloon is filled with physiological saline in the amount of 700 ml then it is added 150 cm 3 of air and 5 cm 3 of a marker.

Landscapes

  • Health & Medical Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Nursing (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

The present invention relates to a process of filling an intragastric balloon placed into the stomach of a patient for the treatment of overweight or obesity. The method consists of filling the intragastric balloon with air or saline combined with a fragrance marker. Preferably, the balloon inflates with saline and gas, usually air, and afterwards the fragrance marker is given to the balloon. Then at 400-700 ml of saline 50-150 cm3 of air at atmospheric pressure is introduced into the balloon. Fragrance marker is chosen such that it is soluble in physiological saline. The best markers used are peppermint flavor with density at 20° C of 0,943-1,003 g / cm3 or eucalyptus-mint flavor with density at 20° C of 0,821 g / cm3 in the amount of 2-5 cm3.

Description

The method of filling an intragastric balloon
The present invention relates to a process of filling an intragastric balloon placed into the stomach of a patient for the treatment of overweight or obesity.
For the treatment of obesity or overweight into the stomach of a patient endoscopically is introduced a soft balloon. Introduced into the stomach is a probe with the balloon which when placed in the stomach is filled with saline or seldom with air. The material of which the balloon is made is resistant to gastric juices. The balloon is left in the stomach of the patient for up to 6 or 12 months. After the placement of a balloon the patient receives individual guidance on nutrition and diet. A balloon partially filling the stomach causes a feeling of satiety after eating less food.
Immediately after surgery most patients have dyspeptic symptoms - nausea and vomiting. Sometimes there are also flatulence, cramping or diarrhea. In the case of balloons filled with saline patients feel gastric heaviness, while in the case of air-filled balloons patients experience stomach approaching to the throat. The presence of the balloon in the stomach causes the patient to reduce the amount of food consumed at one time and to get accustomed to the rational method of nutrition. After the treatment period the balloon is removed by a doctor in endoscopic control.
A balloon placed in the stomach is resistant to gastric contents. However, sometimes there is a risk of a balloon damage and deflation. In this case the patient should immediately contact a doctor to remove the remains of the balloon and to avoid a possible intestinal obstruction.
According to the invention, the method consists of filling the intragastric balloon with air or saline combined with a fragrance marker.
Preferably, the balloon inflates with saline and gas, usually air, and afterwards the fragrance marker is given to the balloon. Then at 400-700 ml of saline 50-150 cm3 of air at atmospheric pressure is introduced into the balloon.
Fragrance marker is chosen such that it is soluble in physiological saline.
The best markers used are peppermint flavor with density at 20° C of 0,943- 1 ,003 g / cm3 or eucalyptus-mint flavor with density at 20° C of 0,821 g / cm3 in the amount of 2-5 cm3.
The method of filling an intragastric balloon according to the invention does not alter the process of treatment of patients, however it causes the fact that the patient notices the damage of the balloon by feeling the characteristic smell of the fragrance marker used during a surgery, expelled through the mouth with air from the damaged balloon (the patient "burps" with a characteristic smell) or feels a noticeable change in urine smell. The early removal of the damaged balloon and its replacement with the new one will be possible. Another advantage that is achieved by the introduction of a fragrance marker is the increase of the sterility of the physiological saline. The introduction of air into the balloon filled with saline solution is designed to reduce dyspeptic symptoms, occurring immediately after the placement and inflation, by reducing the pressure of the balloon to the gastric pylorus.
For example, the method of filling the intragastric balloon according to the invention takes place in the following order: the balloon is inserted through the mouth into the stomach of the patient in the control of the video- endoscope, then by the syringe the balloon is filled with saline solution in the amount of 400 ml, and 50 cm3 of the air from the operating room is added to the balloon by the same syringe, and then 2 cm3 of peppermint flavor (or mint-eucalyptus) is injected into it. The flavor is used as a natural flavoring additive to beverages and beverage concentrates.
In another case the balloon is filled with physiological saline in the amount of 700 ml then it is added 150 cm3 of air and 5 cm3 of a marker.
In the case of the balloon filled only with air it is injected only 5 cm3 of peppermint marker (or mint-eucalyptus), where it evaporates and its vapors cause the air to give the characteristic odor appearing in a balloon.

Claims

Claims:
1. The method of filling an intragastric balloon, using gas or physiological saline, characterized in that to air or physiological saline is added a fragrance marker
2. The method of filling an intragastric balloon according to claim 1 , characterized in that with physiological saline the balloon is filled with gas, preferably air, afterwards a fragrance marker is added.
3. The method of filling an intragastric balloon according to claim 2, characterized in that at 400-700 ml of saline 50-150 cm3 of air at atmospheric pressure is introduced into the balloon.
4. The method of filling an intragastric balloon according to claim 2, characterized in that as a fragrance marker is used peppermint flavor with density at 20° C of 0,943-1,003 g / cm3 or eucalyptus-mint flavor with density at 20° C of 0,821 g / cm3 in the amount of 2-5 cm3.
PCT/PL2012/000091 2011-09-14 2012-09-12 The method of filling an intragastric balloon Ceased WO2013039412A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PLP396288 2011-09-14
PL396288A PL396288A1 (en) 2011-09-14 2011-09-14 Method for filling the intragastric balloon

Publications (1)

Publication Number Publication Date
WO2013039412A1 true WO2013039412A1 (en) 2013-03-21

Family

ID=47073485

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/PL2012/000091 Ceased WO2013039412A1 (en) 2011-09-14 2012-09-12 The method of filling an intragastric balloon

Country Status (2)

Country Link
PL (1) PL396288A1 (en)
WO (1) WO2013039412A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9445930B2 (en) 2004-11-19 2016-09-20 Fulfillium, Inc. Methods, devices, and systems for obesity treatment
US9456915B2 (en) 2004-11-19 2016-10-04 Fulfilium, Inc. Methods, devices, and systems for obesity treatment

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5259399A (en) * 1992-03-02 1993-11-09 Alan Brown Device and method of causing weight loss using removable variable volume intragastric bladder
US20050267596A1 (en) * 2004-05-03 2005-12-01 Fulfillium, Inc. A Delaware Corporation Devices and systems for gastric volume control
US20090082644A1 (en) * 2007-03-15 2009-03-26 Jiayi Li Devices, Systems, Kits and Methods for Treatment of Obesity
US20100168782A1 (en) * 2008-12-27 2010-07-01 John Hancock High specific gravity intragastric device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5259399A (en) * 1992-03-02 1993-11-09 Alan Brown Device and method of causing weight loss using removable variable volume intragastric bladder
US20050267596A1 (en) * 2004-05-03 2005-12-01 Fulfillium, Inc. A Delaware Corporation Devices and systems for gastric volume control
US20090082644A1 (en) * 2007-03-15 2009-03-26 Jiayi Li Devices, Systems, Kits and Methods for Treatment of Obesity
US20100168782A1 (en) * 2008-12-27 2010-07-01 John Hancock High specific gravity intragastric device

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9445930B2 (en) 2004-11-19 2016-09-20 Fulfillium, Inc. Methods, devices, and systems for obesity treatment
US9456915B2 (en) 2004-11-19 2016-10-04 Fulfilium, Inc. Methods, devices, and systems for obesity treatment
US9808367B2 (en) 2004-11-19 2017-11-07 Fulfillium, Inc. Methods, devices, and systems for obesity treatment
US10179060B2 (en) 2004-11-19 2019-01-15 Fulfillium, Inc. Methods, devices, and systems for obesity treatment
US10285835B2 (en) 2004-11-19 2019-05-14 Fulfillium, Inc. Methods, devices, and systems for obesity treatment
US10524946B2 (en) 2004-11-19 2020-01-07 Fulfillium, Inc. Methods, devices, and systems for obesity treatment
US11026825B2 (en) 2004-11-19 2021-06-08 Fulfillium, Inc. Methods, devices, and systems for obesity treatment

Also Published As

Publication number Publication date
PL396288A1 (en) 2013-03-18

Similar Documents

Publication Publication Date Title
Loffredo et al. Three Years Experience with the New Intragastric Balloon, and A Preoperative Test for Success witb Restrictive Surgery
CA2607074C (en) Percutaneous intragastric balloon device and method
US6981980B2 (en) Self-inflating intragastric volume-occupying device
US6454785B2 (en) Percutaneous intragastric balloon catheter for the treatment of obesity
Spivak et al. Avoiding postoperative complications with the LAP-BAND system
US20060155259A1 (en) Stomach balloon that can be inserted and removed via mouth
CN101415382A (en) Expandable digestive pill
CN105250060B (en) A kind of stomach volume reduction slimming capsule
Staudenmann et al. Endoscopic bariatric therapies for obesity: a review
CN205041579U (en) Stomach subtracts appearance capsule with automatic inflation function
US20190099331A1 (en) Bariatric Device and Method
WO2013039412A1 (en) The method of filling an intragastric balloon
CN104623788A (en) Multifunctional stomach tube with expansion balloon
CN101249006A (en) Self-inflating air bag in digestive tract cavity
EP1929957A1 (en) Balloon to be placed in stomach and vehicle for balloon
Neto et al. An alternative approach to intragastric balloon retrieval
US11179257B2 (en) Expandable intragastric device
WO2008037890A3 (en) Intragastric balloon with marked catheter
WO2006022709A1 (en) Food extraction apparatus and method
Khanna Endoluminal Bariatric Surgery: Emerging Trends and Techniques
Katerina et al. Intragastric balloon as an alternative restrictive procedure for morbid obesity
Singh et al. Abnormally Large Wooden Foreign Body Impacted in the Rectosigmoid Colon without Bowel Perforation
TWM312987U (en) Nasogastric tube with balloon-like means for weight loss

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12777951

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12777951

Country of ref document: EP

Kind code of ref document: A1